Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metformin for Treatment Antipsychotic-induced Metabolic Syndrome in Bipolar Disorder Patients

NCT02644577 is registered in ClinicalTrials.gov with China Medical University, China as lead sponsor.

NCT NCT02644577
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02644577 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metformin for Treatment Antipsychotic-induced Metabolic Syndrome in Bipolar Disorder Patients
Lead sponsor
China Medical University, China
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2012
Completion date
September 30, 2015
Enrollment
110 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder